This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...tions are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
more
Health Systems in Transition. Vol. 5 No.3 2015
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
DRUGS REGULATORY UNIT | NOVEMBER 2009 | SECOND EDITION
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Therapeutics Information and Pharmacovigilance Centre | TIPC
Framework for implementation.
The END TB Strategy.
A Handbook for country programmes
Stop TB Communicable Diseases
Guidance on Implending Publi-Private Mix Approaches